Principal Investigator/Program Director (Last, first, middle): Wilson, Teresa, M PROJECT SUMMARY/ABSTRACT The most important risk factor for the development of colorectal cancer is age: greater than 90% of people diagnosed with colorectal cancer are 50 or older. A gender-based difference exists as well. With considerations for age and race/ethnicity, colorectal cancer incidence and mortality rates are more than 35% higher in men than in women. Age and gender also affect the occurrence of microsatellite instability (MSI), a hallmark of defects in the mismatch repair pathway (MMR), in both sporadic and inherited colorectal tumors. Women in general are less likely than men to have MSI positive tumors at a young age, a trend that is maintained in older women undergoing hormone replacement therapy. The MMR pathway performs a critical role in the maintenance of genomic stability by repairing mismatches and insertion/deletion loops in DNA and by signaling for programmed cell death in response to DNA damage. We have found that MMR deficient cells are more resistant to apoptosis and cell death induced by treatment with estrogen. Additionally, we have found that estrogen enhances the interaction between the estrogen receptor beta (ER), the major ER isoform in the colon, and the MMR lesion recognition complexes. The main goal of this proposal is to test the hypothesis that ER, estrogen, and the human mismatch repair proteins function together to maintain genomic integrity. This will be accomplished in three Specific Aims: (1) Specific Aim 1 will test the hypothesis that estrogen and ER enhance the mismatch repair-dependent cellular response to DNA damage; (2) Specific Aim 2 will test the hypothesis that E2 and ER enhance MMR DNA repair activities; and (3) Specific Aim 3 will test the hypothesis that the MMR proteins modulate the biochemical activities of ER. Project Description Page 6

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA095690-04S1
Application #
7487226
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Okano, Paul
Project Start
2003-07-10
Project End
2008-02-29
Budget Start
2007-09-01
Budget End
2008-02-29
Support Year
4
Fiscal Year
2007
Total Cost
$27,900
Indirect Cost
Name
University of Maryland Baltimore
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
McDowell, Heather D; Carney, James P; Wilson, Teresa M (2008) Inhibition of the 5'to 3'exonuclease activity of hEXO1 by 8-oxoguanine. Environ Mol Mutagen 49:388-98
Doherty, Kevin M; Sharma, Sudha; Uzdilla, Laura A et al. (2005) RECQ1 helicase interacts with human mismatch repair factors that regulate genetic recombination. J Biol Chem 280:28085-94
Bai, Haibo; Jones, Sian; Guan, Xin et al. (2005) Functional characterization of two human MutY homolog (hMYH) missense mutations (R227W and V232F) that lie within the putative hMSH6 binding domain and are associated with hMYH polyposis. Nucleic Acids Res 33:597-604